View up-to-date information on ChemoCentryx Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
03 Aug 2022 | Amgen to Acquire ChemoCentryx | Acquisition |
Amgen Inc
|
ChemoCentryx Inc |
27 Aug 2020 | Phase 2 Study of Avacopan for Treatment of C3G, IND 132321, Orphan Designation 16-5590 | Grant |
US Food and Drug Administration
|
ChemoCentryx Inc |
17 Aug 2020 | ChemoCentryx Enters API Manufacturing Agreement with Hovione FarmaCiencia for Avacopan | Contract Service Agreement |
ChemoCentryx Inc
|
Hovione FarmaCiencia SA
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer